Japan Pharmaceutical Market Share

Statistics for the 2023 & 2024 Japan Pharmaceutical market share, created by Mordor Intelligence™ Industry Reports. Japan Pharmaceutical share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Japan Pharmaceutical Industry

The competitive landscape of the Japanese pharmaceutical market covers the business overview, financials, products, and strategies followed by major companies. The pharmaceutical market in Japan is highly competitive and consists of several major players. In terms of market share, a few major players are dominating the market studied. Some prominent players are vigorously making acquisitions and joint ventures with other companies to consolidate their market positions in the country. Some key companies currently dominating the market are Takeda Pharmaceutical Company Limited, Pfizer Inc., Chugai Pharmaceutical Co. Ltd, Merck & Co. Inc., and Daiichi Sankyo Company, Limited, among others.

Japan Pharmaceutical Market Leaders

  1. Takeda Pharmaceutical Company Limited

  2. Pfizer Inc.

  3. Chugai Pharmaceutical Co., Ltd.

  4. Merck & Co., Inc.

  5. Daiichi Sankyo Company, Limited

*Disclaimer: Major Players sorted in no particular order

Japan Pharmaceutical Market Concentration

Japan Pharmaceutical Market Size - Industry Report on Share, Growth Trends & Forecasts Analysis (2024 - 2029)